112 related articles for article (PubMed ID: 38259153)
1. Red cell membrane-coating Prussian blue for combined photothermal and NO gas therapy for nasopharyngeal carcinoma.
Wang W; Cheng Z; Xing H; Zhou S; Ye Q; Xiong G; Wang G; Ma D
J Mater Chem B; 2024 Feb; 12(6):1579-1591. PubMed ID: 38259153
[TBL] [Abstract][Full Text] [Related]
2. Bufotalin-loaded biomimetic Prussian blue nanoparticles for colorectal cancer chemo-photothermal ferroptosis therapy.
Wu Y; Tian J; Yang J; Peng Q; Wu Z; Liu R; Luo M; Qiu Y; Cao R
Nanomedicine (Lond); 2024 Jan; 19(2):109-125. PubMed ID: 38197393
[No Abstract] [Full Text] [Related]
3. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
[TBL] [Abstract][Full Text] [Related]
4. Designed formation of Prussian Blue/CuS Janus nanostructure with enhanced NIR-I and NIR-II dual window response for tumor thermotherapy.
Li D; Wang T; Li L; Zhang L; Wang C; Dong X
J Colloid Interface Sci; 2022 May; 613():671-680. PubMed ID: 35065441
[TBL] [Abstract][Full Text] [Related]
5. Prussian blue/serum albumin/indocyanine green as a multifunctional nanotheranostic agent for bimodal imaging guided laser mediated combinatorial phototherapy.
Sahu A; Lee JH; Lee HG; Jeong YY; Tae G
J Control Release; 2016 Aug; 236():90-9. PubMed ID: 27349352
[TBL] [Abstract][Full Text] [Related]
6. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
7. Prussian blue-coated lanthanide-doped core/shell/shell nanocrystals for NIR-II image-guided photothermal therapy.
Wang X; Li H; Li F; Han X; Chen G
Nanoscale; 2019 Nov; 11(45):22079-22088. PubMed ID: 31720650
[TBL] [Abstract][Full Text] [Related]
8. NIR-II Absorbing Conjugated Polymer Nanotheranostics for Thermal Initiated NO Enhanced Photothermal Therapy.
Chang K; Sun X; Qi Q; Fu M; Han B; Zhang Y; Zhao W; Ni T; Li Q; Yang Z; Ge C
Biosensors (Basel); 2023 Jun; 13(6):. PubMed ID: 37367007
[TBL] [Abstract][Full Text] [Related]
9. RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer.
Liu B; Wang W; Fan J; Long Y; Xiao F; Daniyal M; Tong C; Xie Q; Jian Y; Li B; Ma X; Wang W
Biomaterials; 2019 Oct; 217():119301. PubMed ID: 31279101
[TBL] [Abstract][Full Text] [Related]
10. NIR-II light triggered nitric oxide release nanoplatform combined chemo-photothermal therapy for overcoming multidrug resistant cancer.
Wang J; Wu C; Qin X; Huang Y; Zhang J; Chen T; Wang Y; Ding Y; Yao Y
J Mater Chem B; 2021 Feb; 9(6):1698-1706. PubMed ID: 33495772
[TBL] [Abstract][Full Text] [Related]
11. Near Infrared-Triggered Theranostic Nanoplatform with Controlled Release of HSP90 Inhibitor for Synergistic Mild Photothermal and Enhanced Nanocatalytic Therapy with Hypoxia Relief.
Tian B; Wang C; Du Y; Dong S; Feng L; Liu B; Liu S; Ding H; Gai S; He F; Yang P
Small; 2022 Jul; 18(28):e2200786. PubMed ID: 35661402
[TBL] [Abstract][Full Text] [Related]
12. Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation.
Huang X; Chen L; Lin Y; Tou KI; Cai H; Jin H; Lin W; Zhang J; Cai J; Zhou H; Pi J
Acta Biomater; 2021 Dec; 136():456-472. PubMed ID: 34562660
[TBL] [Abstract][Full Text] [Related]
13. Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer.
Jing L; Liang X; Deng Z; Feng S; Li X; Huang M; Li C; Dai Z
Biomaterials; 2014 Jul; 35(22):5814-21. PubMed ID: 24746962
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte-Membrane-Coated Prussian Blue/Manganese Dioxide Nanoparticles as H
Peng J; Yang Q; Li W; Tan L; Xiao Y; Chen L; Hao Y; Qian Z
ACS Appl Mater Interfaces; 2017 Dec; 9(51):44410-44422. PubMed ID: 29210279
[TBL] [Abstract][Full Text] [Related]
15. PEGylated Prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photothermal therapy.
Cheng L; Gong H; Zhu W; Liu J; Wang X; Liu G; Liu Z
Biomaterials; 2014 Dec; 35(37):9844-9852. PubMed ID: 25239041
[TBL] [Abstract][Full Text] [Related]
16. Plasmonic MoO
Odda AH; Xu Y; Lin J; Wang G; Ullah N; Zeb A; Liang K; Wen LP; Xu AW
J Mater Chem B; 2019 Mar; 7(12):2032-2042. PubMed ID: 32254807
[TBL] [Abstract][Full Text] [Related]
17. A novel NIR-controlled NO release of sodium nitroprusside-doped Prussian blue nanoparticle for synergistic tumor treatment.
Feng T; Wan J; Li P; Ran H; Chen H; Wang Z; Zhang L
Biomaterials; 2019 Sep; 214():119213. PubMed ID: 31146175
[TBL] [Abstract][Full Text] [Related]
18. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
19. Prussian blue-modified ferritin nanoparticles for effective tumor chemo-photothermal combination therapy via enhancing reactive oxygen species production.
Li H; Zhang W; Ding L; Li XW; Wu Y; Tang JH
J Biomater Appl; 2019 Apr; 33(9):1202-1213. PubMed ID: 30714472
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
